Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Cosciens Biopharma Inc.
Aeterna Zentaris to Present at 11th Annual JMP Securities Research Conference in San Francisco
Published May 3 2012
3 min read

Aeterna Zentaris to Present at 11th Annual JMP Securities Research Conference in San Francisco

QUÉBEC CITY, May 3, 2012 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its Senior VP and Chief Medical Officer, Paul Blake MD, will be presenting a corporate overview at the 11th Annual JMP Securities Research Conference on Monday, May 14, 2012, at 12 noon (Pacific), in the Terrace Room of the Ritz-Carlton Hotel in San Francisco.

A live webcast of this presentation will be available on Aeterna Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris

Aeterna Zentaris is an oncology and endocrinology drug development company currently investigating treatments for various unmet medical needs. The Company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. For more information please visit www.aezsinc.com.

Investor Relations
Ginette Beaudet Vallières
Investor Relations Coordinator
(418) 652-8525 ext. 265
gvallieres@aezsinc.com

Media Relations
Paul Burroughs
Director of Communications
(418) 652-8525 ext. 406
pburroughs@aezsinc.com